Alivas
Alivas Inc.
Tokyo, Japan · Founded 2017 · $3.5M raised
- Headquarters
- Tokyo
- Founded
- 2017
- Business Model
- B2B
- Website
- alivas.co.jp
- Total Funding
- $3.5M
- Last Round
- $3.5M Series BApr 2023
- Rounds
- 1
About
Alivas Inc. is a Tokyo-based medical device startup originating from the Japan Biodesign program, focused on developing a novel minimally invasive, one-time treatment option for refractory chronic constipation. Chronic constipation affects approximately 14% of the general population and carries an annual economic burden of around $7,500 per patient; current treatments range from inadequate medication to highly invasive surgical colectomy. Alivas's device is designed to fill this unmet medical need by providing an effective alternative that does not compromise patients' quality of life.
Summary
Alivas is a Biotech company based in Tokyo, Japan, founded in 2017. It has raised $3.5M in total across 1 round, most recently a $3.5M Series B round in Apr 2023. Investors include MedVenture.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2023
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/alivas"><img src="https://indexed.vc/api/badge/company/alivas" alt="Alivas on Indexed.vc" width="260" height="76" /></a>